Hydroxychloroquine Attenuates Myocardial Ischemic and Post-Ischemic Reperfusion Injury by Inhibiting the Toll-Like Receptor 9 – Type I Interferon Pathway. ccm [Internet]. 2022 Aug. 25 [cited 2026 Sep. 18];6(4):416-23. Available from: https://fortunejournals.org/ojs/index.php/ccm/article/view/16285